1. Home
  2. PRPO vs CAUD Comparison

PRPO vs CAUD Comparison

Compare PRPO & CAUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • CAUD
  • Stock Information
  • Founded
  • PRPO N/A
  • CAUD 2019
  • Country
  • PRPO United States
  • CAUD United States
  • Employees
  • PRPO N/A
  • CAUD N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • CAUD Finance: Consumer Services
  • Sector
  • PRPO Industrials
  • CAUD Finance
  • Exchange
  • PRPO Nasdaq
  • CAUD Nasdaq
  • Market Cap
  • PRPO 8.8M
  • CAUD 7.3M
  • IPO Year
  • PRPO N/A
  • CAUD N/A
  • Fundamental
  • Price
  • PRPO $4.44
  • CAUD $0.45
  • Analyst Decision
  • PRPO
  • CAUD
  • Analyst Count
  • PRPO 0
  • CAUD 0
  • Target Price
  • PRPO N/A
  • CAUD N/A
  • AVG Volume (30 Days)
  • PRPO 5.9K
  • CAUD 121.3K
  • Earning Date
  • PRPO 08-15-2024
  • CAUD 08-21-2024
  • Dividend Yield
  • PRPO N/A
  • CAUD N/A
  • EPS Growth
  • PRPO N/A
  • CAUD N/A
  • EPS
  • PRPO N/A
  • CAUD N/A
  • Revenue
  • PRPO $15,812,000.00
  • CAUD $12,142,099.00
  • Revenue This Year
  • PRPO $75.18
  • CAUD N/A
  • Revenue Next Year
  • PRPO N/A
  • CAUD N/A
  • P/E Ratio
  • PRPO N/A
  • CAUD N/A
  • Revenue Growth
  • PRPO 61.64
  • CAUD N/A
  • 52 Week Low
  • PRPO $4.31
  • CAUD $0.35
  • 52 Week High
  • PRPO $8.99
  • CAUD $38.40
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 29.52
  • CAUD 42.59
  • Support Level
  • PRPO $4.31
  • CAUD $0.49
  • Resistance Level
  • PRPO $5.12
  • CAUD $0.55
  • Average True Range (ATR)
  • PRPO 0.37
  • CAUD 0.06
  • MACD
  • PRPO -0.03
  • CAUD -0.00
  • Stochastic Oscillator
  • PRPO 10.74
  • CAUD 16.99

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About CAUD Collective Audience Inc..

Collective Audience Inc is a provider of e-commerce and digital customer acquisition solutions by simplifying digital advertising. It provides a platform that brings you all the latest trends, news, and strategies to use from the collective intelligence of their contributors. The company's digital marketing business includes a holistic, self-serve ad tech platform. Its proprietary data-driven, AI-powered solutions allows brands and agencies to advertise across thousands of the world's leading digital and connected TV publishers.

Share on Social Networks: